Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Randomized Trial to Determine the Efficacy and Safety of Cardene Intravenous (I.V.) Versus Labetalol for Management of Hypertensive Emergencies in the Emergency Department Setting

NCT00765648 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00765648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00765648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Randomized Trial to Determine the Efficacy and Safety of Cardene Intravenous (I.V.) Versus Labetalol for Management of Hypertensive Emergencies in the Emergency Department Setting
Lead sponsor
The Cleveland Clinic
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2008
Completion date
January 31, 2010
Enrollment
226 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertensive urgency